Hamburg, 15 October 2021 How herpes seizes proteins’ means of production The Graham and Crump groups at the University of Cambridge and the Svergun Group at EMBL Hamburg have discovered a mechanism by which the herpes simplex virus takes control of the molecular machinery of human cells. Their work reveals how a dedicated viral protein hijacks key host proteins, forcing the host cell to produce and release copies of the virus. more

Hamburg, 6 October 2021 From creating new antimicrobials to combating Alzheimer’s disease What do Alzheimer’s disease, dental cavities, and a blocked sink drain have in common? They can all involve nanometre-sized bacterial protein fibres that can form molecular constructions as strong as steel. more

Hamburg, 20 August 2021 Welcome Liz Duke The new team leader at EMBL Hamburg talks about her plans to establish biological X-ray imaging and high-throughput tomography. more

Hamburg, 27 July 2021 Studying coronavirus proteins using small-angle X-ray scattering at European XFEL Researchers establish a framework for identifying new drugs capable of exploiting a cell’s own machinery. more

Hamburg, 9 July 2021 From antibodies to nanoplastics EMBL’s Melissa Graewert and colleagues are taking a structural biologist’s approach to better understanding nanoplastic particles. more

Hamburg, 25 June 2021 Structural biology reveals new opportunities to combat tuberculosis EMBL Hamburg’s Wilmanns and Kosinski groups have determined the detailed structure of a bacterial protein complex critical for tuberculosis infection. more

Hamburg, 17 May 2021 Reshaping the cell membrane with molecular pegs Researchers at EMBL Hamburg reveal how peg-like proteins clasp and reshape the cell membrane more

Hamburg, 9 April 2021 EMBL Hamburg lights the way to folding next-level origami Using EMBL Hamburg’s world-class structural biology infrastructure, researchers advance the folding of protein ‘origami’ designed in the lab. more

Hamburg, 14 January 2021 Toadlet peptide transforms into a deadly weapon against bacteria Researchers at the Technion – Israel Institute of Technology and EMBL Hamburg have discovered remarkable molecular properties of an antimicrobial peptide from the skin of the Australian toadlet. The discovery could inspire the development of novel synthetic drugs to combat bacterial infections more

Hamburg, 1 December 2020 EMBL facilities support development of RNA vaccines BioNTech and Mainz University collaborate with EMBL scientists at the beamline P12 in Hamburg more